Cypress Capital, LLC Abb Vie Inc. Transaction History

Cypress Capital, LLC

$388 Billion
Q3 2024

A detailed history of Cypress Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cypress Capital, LLC holds 15,398 shares of ABBV stock, worth $2.54 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

15,398

Previous 907 1597.68%

Holding current value

$2.54 Million

Previous $156 Million 1854.63%

% of portfolio

0.78%

Previous 0.49%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $2.37 Million - $2.89 Million	14,491 Added 1597.68%	15,398 $3.04 Billion
Q2 2024 Oct 29, 2024	SELL	$154.79 - $180.76 $3.14 Million - $3.66 Million	-20,264 Reduced 95.72%	907 $156 Million
Q2 2024 Oct 28, 2024	SELL	$154.79 - $180.76 $2.15 Million - $2.51 Million	-13,862 Reduced 93.86%	907 $156 Million
Q2 2024 Aug 22, 2024	SELL	$154.79 - $180.76 $953,970 - $1.11 Million	-6,163 Reduced 29.44%	14,769 $2.53 Million
Q1 2024 Oct 29, 2024	BUY	$159.82 - $182.1 $3.24 Million - $3.69 Million	20,264 Added 2234.18%	21,171 $3.86 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $23,254 - $26,189	169 Added 0.81%	20,932 $3.24 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $90,841 - $105,162	-680 Reduced 3.17%	20,763 $3.09 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $54,594 - $67,938	412 Added 1.96%	21,443 $2.89 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $379,022 - $436,501	-2,621 Reduced 11.08%	21,031 $3.35 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $10,373 - $12,440	75 Added 0.32%	23,652 $3.82 Million
Q3 2022 Feb 01, 2023	BUY	$134.21 - $153.93 $71,668 - $82,198	534 Added 2.32%	23,577 $3.16 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $457,861 - $582,091	-3,327 Reduced 12.62%	23,043 $3.53 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $139,898 - $173,575	1,060 Added 4.19%	26,370 $4.28 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $131,709 - $166,650	-1,226 Reduced 4.62%	25,310 $3.43 Million
Q3 2021 Feb 10, 2022	BUY	$106.4 - $120.78 $54,264 - $61,597	510 Added 1.96%	26,536 $2.86 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $199,372 - $222,112	1,895 Added 7.85%	26,026 $2.93 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $89,921 - $98,992	879 Added 3.78%	24,131 $2.61 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $28,251 - $38,143	-351 Reduced 1.49%	23,252 $2.49 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $222,249 - $260,847	-2,587 Reduced 9.88%	23,603 $2.03 Million
Q2 2020 Aug 20, 2020	BUY	$73.37 - $98.18 $1.92 Million - $2.57 Million	26,190 New	26,190 $2.57 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.

Account

Cypress Capital, LLC Abb Vie Inc. Transaction History